Sharon P Wilczynski Selected Research

Sharon P Wilczynski Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 08/2002
7	Ovarian Neoplasms (Ovarian Cancer) 08/2009 - 04/2003
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 08/2002
4	Breast Neoplasms (Breast Cancer) 01/2016 - 03/2008
3	Carcinoma (Carcinomatosis) 03/2009 - 01/2008
3	Adenocarcinoma 03/2009 - 04/2003
2	Neoplasm Metastasis (Metastasis) 01/2012 - 09/2003
2	Ovarian Epithelial Carcinoma 01/2009 - 03/2005
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2024
1	Genomic Instability 12/2020
1	Hyperplasia 01/2016
1	Carcinogenesis 08/2009
1	Squamous Cell Carcinoma of Head and Neck 05/2009
1	Carcinoma in Situ 04/2009
1	Pleural Effusion (Pleural Effusions) 03/2009
1	Sarcoma (Soft Tissue Sarcoma) 03/2008
1	Aspergillosis 09/2006
1	Infections 09/2006
1	Disease Progression 03/2005
1	Endometrial Neoplasms (Endometrial Cancer) 03/2005
1	Skin Neoplasms (Skin Cancer) 11/2003
1	Virus Diseases (Viral Diseases) 11/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2003
1	Basal Cell Carcinoma (Rodent Ulcer) 11/2003
1	Warts (Wart) 11/2003
1	Papillomavirus Infections 04/2003
1	Neutropenia 04/2003
1	Nausea 04/2003
1	Vomiting 04/2003
1	Lethargy 04/2003
1	Fatigue 04/2003
1	Jaundice (Icterus) 01/2003

Drug/Important Bio-Agent (IBA)

5	Paclitaxel (Taxol)FDA LinkGeneric 08/2009 - 04/2003
4	Carboplatin (JM8)FDA LinkGeneric 03/2009 - 03/2005
3	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 04/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 09/2003
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2005
3	KalininIBA 03/2012 - 03/2008
3	AntibodiesIBA 04/2009 - 03/2005
2	Small Interfering RNA (siRNA)IBA 01/2024 - 12/2020
2	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2012
2	Estrogen ReceptorsIBA 03/2012 - 03/2008
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2012 - 03/2008
2	liposomal doxorubicin (Doxil)FDA Link 08/2009 - 01/2008
2	Messenger RNA (mRNA)IBA 05/2009 - 04/2003
2	Laminin (Merosin)IBA 04/2009 - 03/2008
2	PlatinumIBA 01/2009 - 01/2008
2	trichostatin A (A 300)IBA 09/2008 - 08/2002
1	matrigelIBA 01/2024
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2016
1	Tamoxifen FDA LinkGeneric 01/2016
1	ErbB Receptors (EGF Receptor)IBA 03/2012
1	SilverIBA 03/2012
1	Extracellular Matrix ProteinsIBA 03/2012
1	NucleotidesIBA 08/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2009
1	IntegrinsIBA 04/2009
1	Integrin alpha3IBA 04/2009
1	Conditioned Culture MediaIBA 04/2009
1	Cathepsin LIBA 09/2008
1	Cysteine Proteinase InhibitorsIBA 09/2008
1	Cystatin MIBA 09/2008
1	Peptide Hydrolases (Proteases)FDA Link 09/2008
1	Keratin-5 (Keratin 5)IBA 03/2008
1	1-dodecylpyridoxal (PLD)IBA 01/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2006
1	VaccinesIBA 09/2006
1	Asp f 3 allergenIBA 09/2006
1	AntigensIBA 08/2006
1	RNA (Ribonucleic Acid)IBA 08/2006
1	Amifostine (Ethyol)FDA LinkGeneric 03/2005
1	A-factor (Streptomyces)IBA 03/2005
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2005
1	LigandsIBA 03/2005
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 03/2005
1	Stem Cell FactorIBA 03/2005
1	Tyrosine Kinase InhibitorsIBA 03/2005
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2005
1	Platelet-Derived Growth Factor alpha ReceptorIBA 03/2005
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 03/2005
1	CarcinogensIBA 01/2005
1	Benzo(a)pyreneIBA 01/2005
1	Urethane (Ethyl Carbamate)IBA 01/2005
1	Fluorescein (Funduscein)FDA LinkGeneric 08/2002

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 08/2009 - 04/2003
4	Therapeutics 08/2009 - 04/2003
2	Neoadjuvant Therapy 03/2009 - 01/2009
1	Combined Modality Therapy 05/2009
1	Cytoreduction Surgical Procedures 01/2009
1	Time-to-Treatment 01/2008
1	Stem Cell Transplantation 07/2004
1	Hysterectomy 09/2003
1	Radiotherapy 09/2003
1	Lymph Node Excision (Lymph Node Dissection) 09/2003
1	Cholecystectomy 01/2003